|
業務類別
|
-- |
|
業務概覽
|
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201). |
| 公司地址
| 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112 |
| 電話號碼
| +1 720 437-6500 |
| 傳真號碼
| +1 720 437-6501 |
| 公司網頁
| https://www.ampiopharma.com |
| 員工數量
| 6 |
| Mr. Michael A. Martino |
Director and Chief Executive Officer |
-- |
27/03/2024 |
| Mr. Daniel G. Stokely |
Chief Financial Officer, Chief Accounting Officer and Secretary |
-- |
27/03/2024 |
|
|
| Mr. Michael A. Martino |
Director and Chief Executive Officer |
27/03/2024 |
| Dr. David R. Stevens,PhD |
Independent Director |
27/03/2024 |
| Mr. J. Kevin Buchi |
Chairman of the Board |
27/03/2024 |
| Ms. Elizabeth Varki Jobes, Esq. |
Independent Director |
27/03/2024 |
|
|
|
|
